Michael Mothapo [Data Capturer]

T: +27 (0) 10 001 2665  
Michael Mothapo

Mzwandile Mothapo joined HE2RO as a Research Field Worker in February 2010.He currently is involved in the recruitment, interviewing study participants to gain consent, capturing data from clinic files as well as entering and cleaning data into different electronic record systems. The studies that Mzwandile has worked on include; Cost, Rates and Predictors of the mortality impact of HIV/AIDS in SA, Drug Sensitive TB Study, Early initiation of ART to HIV positive Pregnant women(ANC study),Factors associated with poor Adherence to Antiretroviral therapy among HIV positive Adolescent in SA, RapIT Study, and now RECON. Prior to joining HE2RO  Mzwandile worked as Peer Education Activity  coordinator at a local NGO.

Projects

  • SLATE: Simplified Algorithm for Treatment Eligibility

    In its 2015 revision of the global guidelines for HIV care and treatment, the World Health Organization called for initiating lifelong antiretroviral treatment (ART) for all patients testing positive for HIV, regardless of CD4 cell count. As countries adopt the new recommendation, known as “treat all,” millions of additional patients are becoming eligible for ART worldwide. In sub-Saharan Africa, where most of these patients are located, studies continue to document high losses of 
  • Rewards for TB Contact Screening (RECON)

    Because of the high risk of both TB and HIV among the household contacts of TB patients and the importance of early case detection for both diseases and especially for DR-TB, improving TB case finding is a high priority. Recent studies have shown that having healthcare workers make multiple visits to the homes of TB patients in order to screen household contacts is a logistically challenging and resource- intensive strategy, and it is not routinely undertaken in most public sector settings in 
  • Rapid Initiation of Antiretroviral Treatment (RapIT) for Pregnant Women

    Alongside the primary RapIT study, we are enrolling pregnant women at a public clinic in Johannesburg in a prospective study of the impact of the guidelines on retention on ART for the duration of pregnancy. We are comparing our main outcome, adherence to ART until delivery, for these women to a retrospective comparison group who received PMTCT under earlier 
  • RapIT: Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa

    The RapIT study was a randomized strategy evaluation of the feasibility, effectiveness, and cost-effectiveness of rapid ART initiation using accelerated clinic procedures and point-of-care laboratory tests. Outpatient, non-pregnant, HIV-positive adults who came to two South African clinics for an HIV test or CD4 count, consented to study participation, and were eligible for ART under 2010 guidelines were randomized 1:1 to rapid ART initiation or to standard care. Those who were assigned to